Exact Mass: 472.40285719999997
Exact Mass Matches: 472.40285719999997
Found 500 metabolites which its exact mass value is equals to given mass value 472.40285719999997
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Soyasapogenol D
Soyasapogenol D is a triterpenoid. Soyasapogenol D is a natural product found in Glycine max, Medicago sativa, and other organisms with data available. See also: Trifolium pratense flower (part of). Soybean saponin (from Glycine max). Soyasapogenol D is found in pulses. Soyasapogenol D is found in pulses. Soybean saponin (from Glycine max)
alpha-Tocopherol acetate
D020011 - Protective Agents > D000975 - Antioxidants > D024505 - Tocopherols Vitamin E supplement and antioxidant for foodstuffs Vitamin E supplement and antioxidant for foodstuff D018977 - Micronutrients > D014815 - Vitamins Same as: D01735 D-α-Tocopherol acetate (D-Vitamin E acetate) can be hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1]. D-α-Tocopherol acetate (D-Vitamin E acetate) can be hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1].
24-Methyl-24-methoxycycloartanol
24-methyl-24-methoxycycloartanol belongs to cycloartanols and derivatives class of compounds. Those are steroids containing a cycloartanol moiety. 24-methyl-24-methoxycycloartanol is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). 24-methyl-24-methoxycycloartanol can be found in rice, which makes 24-methyl-24-methoxycycloartanol a potential biomarker for the consumption of this food product.
Leucettamol A
C30H52N2O2 (472.40285719999997)
3alpha,21beta-dihydroxy-11alpha-methoxy-olean-12-ene
3??-Methoxy-9??,19-cyclolanost-23(E)-en-25,26-diol
(+)-(20S)-20-(dimethylamino)-16alpha-hydroxy-3beta-(3alpha-isopropyl)-lactam-5alpha-pregn-4-one
(22S,24R)-24-methyllanosta-8-en-22,28-epoxy-3beta,22alpha-diol
(3alpha,22S,25R,26R)-26-methoxy-22,26-epoxylanost-8-en-3-ol|artabotryol C1
Me ester-25-Hydroxy-3, 4-secocycloart-23-en-3-oic acid
dammarenolic acid methyl ester|Dammarenolsaeure-methylester
24-methylenecycloartane-3beta,16beta,23beta-triol|longitriol
Me ester-24-Hydroxy-3, 4-secocycloart-25-en-3-oic acid
cupacinoxepin (5aR,8aR,9aR,10aS,13bR,14bR,17bS,18bS)-4,4,8a,10a,14b,18b,22,22-octamethylperhydronaphtho[1,2-e]benzo[1,2-b:4,3-c]dioxepin-3-one
(3beta,4alpha,5alpha,8beta)-4-methylergost-24(28)-ene-3,8-diol 3-monoacetate
cycloartan-24(24a)-ene-1a,2a,3b?triol|neomacrotriol
5alpha-lanosta-7,9(11)-diene-3beta,25-diol-28-carboxylic acid|sexangulic acid
11-Ac-3beta-3,11-Dihydroxy-9,11-secoergosta-5,24(28)-dien-9-one|3beta-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one
(3beta,24xi)-3-methoxy-24-methyl-9,19-cyclolanostan-25-ol
6beta,12-dihydroxy-11alpha-methoxy-24-norurs-12-en-3-one
(3beta,22beta)-3,22,24-Trihydroxy-12-oleanen-19-one|3beta,22beta,24-Trihydroxyolean-12-en-19-on|Sapogenin III
3beta,28alpha-dihydroxy-16-oxo-13beta,28-oxydooleanane
(22E)-6-O-butylcholesta-7,22-diene-3beta,5alpha,6beta-triol|homaxisterol A1
24-methylenecholestan-3-one-5alpha,6beta-diol-6-acetate
3beta,21beta,22beta-trihydroxyurs-12-en-28-al|cordianal C
(23R,24E)-3beta,23-dihydroxy-9beta-lanosta-7,24-dien-26-oic acid|abiesatrine F
20,24-Epoxy-24-methoxy-23(24-25)abeo-dammaran-3-one
(3beta,22R,23S)-24-Methylenelanost-8-ene-3,22,23-triol
2beta,3beta-dihydroxy-D:C-friedoolean-8-en-29-oic acid|2beta-hydroxybryonolic acid
3alpha,21beta-dihydroxy-11alpha-methoxy-urs-12-ene
20alpha-dimethylamino-3beta-(3,4-dimethylpent-3-enoyl)amino-5alpha-pregnane-4beta-ol|pachysamine P
C30H52N2O2 (472.40285719999997)
20-Me ether-3,20-Dihydroxy-30-nor-12-oleanen-28-oic acid
22alpha-methoxyfaradiol|22alpha-methoxytaraxast-20-ene-3beta,16beta-diol
6beta-acetoxy-(22E)-ergosta-7,22-diene-3beta,5alpha-diol|6??-Acetoxy-(22E)-ergosta-7,22-diene-3??,5??-diol
Ganodermanontriol
Ganodermanontriol is a triterpenoid. It has a role as a metabolite. Ganodermanontriol is a natural product found in Ganoderma leucocontextum, Ganoderma sinense, and other organisms with data available. A natural product found in Ganoderma lucidum.
(5R,5aS,7aR,7bR,9aR,13aR,13bS,15aR,15bR)-icosahydro-15a-(hydroxymethyl)-5,5a,7b,9a,12,12,13b-heptamethylchryseno[1,2-d]oxepine-2,4-dione|2,3-seco-2,3-epoxy-25-hydroxy-2,3-friedelanedione|lobatanhydride
3,7,25-Trihydroxycucurbita-5,23-dien-19-al
3beta,7beta,25-Trihydroxycucurbita-5,23-dien-19-al is a natural product found in Momordica charantia with data available.
Maytenfolic acid
Triptotriterpenic acid A is a pentacyclic triterpenoid with formula C30H48O4, originally isolated from Tripterygium hypoglaucum. It has a role as a plant metabolite. It is a pentacyclic triterpenoid, a hydroxy monocarboxylic acid and a diol. It derives from a hydride of an oleanane. Triptotriterpenic acid A is a natural product found in Euonymus laxiflorus, Salacia chinensis, and other organisms with data available. A pentacyclic triterpenoid with formula C30H48O4, originally isolated from Tripterygium hypoglaucum.
16α-Hydroxytrametenolic acid
60HAB1ZK1T
Pomolic acid is a triterpenoid. It has a role as a metabolite. Pomolic acid is a natural product found in Freziera, Debregeasia saeneb, and other organisms with data available. See also: Sanguisorba officinalis whole (part of). A natural product found particularly in Rosa woodsii and Euscaphis japonica. Randialic acid A (Pomolic acid) is a pentacyclic triterpene isolated from?Euscaphis japonica?(Tunb.). Randialic acid A (Pomolic acid) inhibits tumor cells growth and induces cell apoptosis. Randialic acid A (Pomolic acid) has a potential for the treatment of prostate cancer (PC)[2]. Randialic acid A (Pomolic acid) is a pentacyclic triterpene isolated from?Euscaphis japonica?(Tunb.). Randialic acid A (Pomolic acid) inhibits tumor cells growth and induces cell apoptosis. Randialic acid A (Pomolic acid) has a potential for the treatment of prostate cancer (PC)[2].
Alisol B
Alisol B is a potentially novel therapeutic compound for bone disorders by targeting the differentiation of osteoclasts as well as their functions. IC50 Value: Target: In vitro: The in vitro cultured human renal tubular epithelial HK-2 cells were intervened with 5 ng/mL transforming growth factor-beta (TGF-beta), 0.1 micromol C3a, and 0.1 micromol C3a + 10 micromol alisol B, respectively. Exogenous C3a could induce renal tubular EMT. Alisol B was capable of suppressing C3a induced EMT [1]. Alisol-B strongly inhibited RANKL-induced osteoclast formation when added during the early stage of cultures, suggesting that alisol-B acts on osteoclast precursors to inhibit RANKL/RANK signaling. Among the RANK signaling pathways, alisol-B inhibited the phosphorylation of JNK, which are upregulated in response to RANKL in bone marrow macrophages, alisol-B also inhibited RANKL-induced expression of NFATc1 and c-Fos, which are key transcription factors for osteoclastogenesis. In addition, alisol-B suppressed the pit-forming activity and disrupted the actin ring formation of mature osteoclasts [2]. Alisol B induced calcium mobilization from internal stores, leading to autophagy through the activation of the CaMKK-AMPK-mammalian target of rapamycin pathway. Moreover, the disruption of calcium homeostasis induces endoplasmic reticulum stress and unfolded protein responses in alisol B-treated cells, leading to apoptotic cell death. Finally, by computational virtual docking analysis and biochemical assays, it was showed that the molecular target of alisol B is the sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase [3]. In vivo: Alisol B is a potentially novel therapeutic compound for bone disorders by targeting the differentiation of osteoclasts as well as their functions. IC50 Value: Target: In vitro: The in vitro cultured human renal tubular epithelial HK-2 cells were intervened with 5 ng/mL transforming growth factor-beta (TGF-beta), 0.1 micromol C3a, and 0.1 micromol C3a + 10 micromol alisol B, respectively. Exogenous C3a could induce renal tubular EMT. Alisol B was capable of suppressing C3a induced EMT [1]. Alisol-B strongly inhibited RANKL-induced osteoclast formation when added during the early stage of cultures, suggesting that alisol-B acts on osteoclast precursors to inhibit RANKL/RANK signaling. Among the RANK signaling pathways, alisol-B inhibited the phosphorylation of JNK, which are upregulated in response to RANKL in bone marrow macrophages, alisol-B also inhibited RANKL-induced expression of NFATc1 and c-Fos, which are key transcription factors for osteoclastogenesis. In addition, alisol-B suppressed the pit-forming activity and disrupted the actin ring formation of mature osteoclasts [2]. Alisol B induced calcium mobilization from internal stores, leading to autophagy through the activation of the CaMKK-AMPK-mammalian target of rapamycin pathway. Moreover, the disruption of calcium homeostasis induces endoplasmic reticulum stress and unfolded protein responses in alisol B-treated cells, leading to apoptotic cell death. Finally, by computational virtual docking analysis and biochemical assays, it was showed that the molecular target of alisol B is the sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase [3]. In vivo:
Sumaresinolic acid
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.531 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.529 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.540 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.537
C30H48O4_(2alpha,3beta,5xi,9xi,18xi)-2,3-Dihydroxyolean-12-en-28-oic acid
C30H48O4_(2alpha,3beta,5xi,9xi,13xi,18xi)-2,3-Dihydroxylup-20(29)-en-28-oic acid
Alpha-Tocopherol Acetate
Alpha-Tocopherol acetate is a tocol. D-alpha-tocopheryl acetate appears as odorless off-white crystals. Darkens at 401 °F. (NTP, 1992) - National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina. Alpha-tocopherol is the primary form of vitamin E that is preferentially used by the human body to meet appropriate dietary requirements. In particular, the RRR-alpha-tocopherol (or sometimes called the d-alpha-tocopherol stereoisomer) stereoisomer is considered the natural formation of alpha-tocopherol and generally exhibits the greatest bioavailability out of all of the alpha-tocopherol stereoisomers. Moreover, RRR-alpha-tocopherol acetate is a relatively stabilized form of vitamin E that is most commonly used as a food additive when needed. Alpha-tocopherol acetate is subsequently most commonly indicated for dietary supplementation in individuals who may demonstrate a genuine deficiency in vitamin E. Vitamin E itself is naturally found in various foods, added to others, or used in commercially available products as a dietary supplement. The recommended dietary allowances (RDAs) for vitamin E alpha-tocopherol are: males = 4 mg (6 IU) females = 4 mg (6 IU) in ages 0-6 months, males = 5 mg (7.5 IU) females = 5 mg (7.5 IU) in ages 7-12 months, males = 6 mg (9 IU) females = 6 mg (9 IU) in ages 1-3 years, males = 7 mg (10.4 IU) females = 7 mg (10.4 IU) in ages 4-8 years, males = 11 mg (16.4 IU) females = 11 mg (16.4 IU) in ages 9-13 years, males = 15 mg (22.4 IU) females = 15 mg (22.4 IU) pregnancy = 15 mg (22.4 IU) lactation = 19 mg (28.4 IU) in ages 14+ years. Most individuals obtain adequate vitamin E intake from their diets; genuine vitamin E deficiency is considered to be rare. Nevertheless, vitamin E is known to be a fat-soluble antioxidant that has the capability to neutralize endogenous free radicals. This biologic action of vitamin E consequently continues to generate ongoing interest and study in whether or not its antioxidant abilities may be used to help assist in preventing or treating a number of different conditions like cardiovascular disease, ocular conditions, diabetes, cancer and more. At the moment however, there exists a lack of formal data and evidence to support any such additional indications for vitamin E use. Vitamin E Acetate is the acetate ester of a fat-soluble vitamin with potent antioxidant properties. Considered essential for the stabilization of biological membranes (especially those with high amounts of polyunsaturated fatty acid), vitamin E is a generic name for a group of compounds known as tocopherols and tocotrienols (tocols). This agent is a potent peroxyl radical scavenger and inhibits noncompetitively cyclooxygenase activity in many tissues, resulting in a decrease in prostaglandin production. Vitamin E also inhibits angiogenesis and tumor dormancy through suppressing vascular endothelial growth factor (VEGF) gene transcription. (NCI04) A natural tocopherol and one of the most potent antioxidant tocopherols. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. It has four methyl groups on the 6-chromanol nucleus. The natural d form of alpha-tocopherol is more active than its synthetic dl-alpha-tocopherol racemic mixture. D020011 - Protective Agents > D000975 - Antioxidants > D024505 - Tocopherols D018977 - Micronutrients > D014815 - Vitamins Same as: D01735 D-α-Tocopherol acetate (D-Vitamin E acetate) can be hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1]. D-α-Tocopherol acetate (D-Vitamin E acetate) can be hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1].
Alfacol
D020011 - Protective Agents > D000975 - Antioxidants > D024505 - Tocopherols D018977 - Micronutrients > D014815 - Vitamins D-α-Tocopherol acetate (D-Vitamin E acetate) can be hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1]. D-α-Tocopherol acetate (D-Vitamin E acetate) can be hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1].
(5Z,7E)-(1S,3R)-26,27-diethyl-23-oxa-9,10-seco-5,7,10(19),20-cholestatetraene-1,3,25-triol
1β-butyl-1α,25-dihydroxyvitamin D3 / 1β-butyl-1α,25-dihydroxycholecalciferol
1α-butyl-1β,25-dihydroxyvitamin D3 / 1α-butyl-1β,25-dihydroxycholecalciferol
26,27-diethyl-1α,25-dihydroxyvitamin D3 / 26,27-diethyl-1α,25-dihydroxycholecalciferol
(5Z,7E)-(1S,3R)-26,27-dimethyl-24a,24b-dihomo-9,10-seco-5,7,10(19)-cholestatrien-1,3,25-triol
Lucidumol A
Queretaroic acid
Priverogenin A
(3beta,23xi)-3,23-Dihydroxycycloart-24-en-26-oic acid
Pomolic acid
Randialic acid A (Pomolic acid) is a pentacyclic triterpene isolated from?Euscaphis japonica?(Tunb.). Randialic acid A (Pomolic acid) inhibits tumor cells growth and induces cell apoptosis. Randialic acid A (Pomolic acid) has a potential for the treatment of prostate cancer (PC)[2]. Randialic acid A (Pomolic acid) is a pentacyclic triterpene isolated from?Euscaphis japonica?(Tunb.). Randialic acid A (Pomolic acid) inhibits tumor cells growth and induces cell apoptosis. Randialic acid A (Pomolic acid) has a potential for the treatment of prostate cancer (PC)[2].
20B-hydroxyursolic acid
Azukisapogenol
D-Maslinic acid
Sebiferenic acid
Momordicin I
Constituent of leaves and vines of Momordica charantia (bitter melon). Momordicin I is found in bitter gourd and fruits.
Ganoderic acid U
Epoxyganoderiol A
3,22-Dihydroxycycloart-24-en-26-Oic acid
Albigenic acid
Rubitic acid
Ganoderiol E
3alpha-Corosolic acid
ascr#38
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (20R)-20-hydroxyhenicosanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#38
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 21-hydroxyhenicosanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
1beta-butyl-1alpha,25-dihydroxyvitamin D3 / 1beta-butyl-1alpha,25-dihydroxycholecalciferol
1alpha-butyl-1beta,25-dihydroxyvitamin D3
26,27-diethyl-1alpha,25-dihydroxyvitamin D3 / 26,27-diethyl-1alpha,25-dihydroxycholecalciferol
1alpha,25-dihydroxy-26,27-dimethyl-24a,24b-dihomovitamin D3
Ganodermatriol
Constituent of Ganoderma lucidum (reishi). Ganodermatriol is found in mushrooms.
(2beta,3alpha)-2,3-Dihydroxy-urs-12-en-28-oic acid
(4S)-2α,3β-Dihydroxy-D:C-friedo-B:A-neogammacer-9(11)-en-23-oic acid
Cochalic acid
A pentacyclic triterpenoid that is oleanane which has been substituted by hydroxy groups at the 3beta and 16beta positions, dehydrogenated to introduce a double bond at the 12-13 position, and in which the methyl substituent at position 17 has undergone oxidation to give the corresponding carboxylic acid. Found in the cactus Myrtillocactus cochal.
4-Epihederagenin
A pentacyclic triterpenoid that is the C-4 epimer of hederagenin. It has been isolated from the roots of Rubia yunnanensis.
fatsicarpain E
A pentacyclic triterpenoid that is olean-18-ene substituted by alpha-hydroxy groups at positions 3 and 11 respectively and a carboxy group at position 28. It has been isolated from the leaves and twigs of Fatsia polycarpa.
21-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]heneicosanoic acid
(20R)-20-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]henicosanoic acid
Hederagenol
Hederagenin is a triterpenoid saponin that can inhibit the expression of iNOS, COX-2, and NF-κB in cells caused by LPS stimulation. Hederagenin is a triterpenoid saponin that can inhibit the expression of iNOS, COX-2, and NF-κB in cells caused by LPS stimulation.
Pulchinenoside A_qt
23-hydroxybetulinic acid is one of the bioactive components responsible for its anticancer activity. In vitro: 23-hydroxybetulinic acid also shows different proliferation inhibitory activity against B16, HeLa, and HUVEC, with the IC50 value of 78.5, 80, and 94.8 uM, respectively. 23-hydroxybetulinic acid can promote cell cycle arrest at S phase and induce apoptosis via intrinsic pathway. 23-hydroxybetulinic acid disrupts mitochondrial membrane potential significantly (p<0.01) and selectively downregulates the levels of Bcl-2, survivin and upregulates Bax, cytochrome C, cleaved caspase-9 23-hydroxybetulinic acid can induce apoptosis in K562 cells. [1] 23-hydroxybetulinic acid enhances sensitivity of doxorubicin (DOX, ADR) on MCF-7/ADR cell lines, indicating its potential to be developed as a novel MDR modulator.[2] 23-HBA significantly improve the sensitivity of the tumor to doxorubicin. [3] 23-hydroxybetulinic acid is one of the bioactive components responsible for its anticancer activity. In vitro: 23-hydroxybetulinic acid also shows different proliferation inhibitory activity against B16, HeLa, and HUVEC, with the IC50 value of 78.5, 80, and 94.8 uM, respectively. 23-hydroxybetulinic acid can promote cell cycle arrest at S phase and induce apoptosis via intrinsic pathway. 23-hydroxybetulinic acid disrupts mitochondrial membrane potential significantly (p<0.01) and selectively downregulates the levels of Bcl-2, survivin and upregulates Bax, cytochrome C, cleaved caspase-9 23-hydroxybetulinic acid can induce apoptosis in K562 cells. [1] 23-hydroxybetulinic acid enhances sensitivity of doxorubicin (DOX, ADR) on MCF-7/ADR cell lines, indicating its potential to be developed as a novel MDR modulator.[2] 23-HBA significantly improve the sensitivity of the tumor to doxorubicin. [3]
Echinocystic acid
Echinocystic acid is a pentacyclic triterpene extracted from the fruit of Honey Locust. It has strong antioxidant, anti-inflammatory and anti-tumor properties. Echinocystic acid is a pentacyclic triterpene extracted from the fruit of Honey Locust. It has strong antioxidant, anti-inflammatory and anti-tumor properties.
(17-hydroxy-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-1-yl) dodecanoate
[3-Carboxy-2-(3-hydroxyicosanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(2-hydroxyicosanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(12-hydroxyicosanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(15-hydroxyicosanoyloxy)propyl]-trimethylazanium
TRIPTOTRITERPENIC ACID C
A pentacyclic triterpenoid with formula C30H48O4, originally isolated from the roots of Tripterygium wilfordii.
2alpha,3beta-Dihydroxyolean-13(18)-en-28-oic acid
A pentacyclic triterpenoid that is olean-13(18)-en-28-oic acid substituted by hydroxy groups at positions 2 and 3 (the 2alpha,3beta-stereoisomer). It has been isolated from the leaves of Rosa laevigata.
(4aS,6aS,6bR,10R,11R,12aR)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
3beta-hydroxyfriedelan-23-oic acid
A natural product found in Garcia parviflora.
(1R,3aS,5aR,5bR,9R,10R,11aR)-9,10-dihydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
[(2R)-3-carboxy-2-(18-carboxyoctadecanoyloxy)propyl]-trimethylazanium
C26H50NO6+ (472.36379400000004)
(2α,3β)-2,3-Dihydroxylup-20(29)-en-28-oic acid
[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] pentanoate
[1-hydroxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propan-2-yl] propanoate
(20Z,23Z,26Z,29Z)-dotriaconta-20,23,26,29-tetraenoic acid
2-Trimethylsilyloxyicosanoic acid trimethylsilyl ester
C26H56O3Si2 (472.37677859999997)
[1-carboxy-3-[3-[(E)-hexadec-7-enoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
C26H50NO6+ (472.36379400000004)
[1-carboxy-3-[3-[(Z)-hexadec-9-enoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
C26H50NO6+ (472.36379400000004)
Soyasapogenol D
Soyasapogenol D is a triterpenoid. Soyasapogenol D is a natural product found in Glycine max, Medicago sativa, and other organisms with data available. See also: Trifolium pratense flower (part of).
Tocopheryl acetate
D020011 - Protective Agents > D000975 - Antioxidants > D024505 - Tocopherols D018977 - Micronutrients > D014815 - Vitamins
4,5,10-Trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carbaldehyde
(3b,22S,24E)-3,22-Dihydroxycycloart-24-en-26-oic acid
(17Z,20Z,23Z,26Z)-dotriacontatetraenoic acid
A very long-chain omega-6 fatty acid that is tetracosanoic acid having four double bonds located at positions 17, 20, 23 and 26 (the 17Z,20Z,23Z,26Z-isomer).
(1r,4r,5r,8s,10s,13r,14r,17r,18r,19s,20s)-10-hydroxy-19-(2-hydroxypropan-2-yl)-4,5,9,9,13-pentamethyl-21-oxahexacyclo[18.2.1.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricosan-22-one
(1s,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14br)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
(4as,6as,6br,8ar,10r,11r,12ar,12bs,14bs)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(1r,3ar,5ar,7s,9as,10r,11ar)-7,10-dihydroxy-1-[(5e)-7-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one
(3as,5ar,5br,7as,11ar,11bs,13ar,13br)-1-(2-hydroxypropan-2-yl)-5a,5b,8,8,11a-pentamethyl-9-oxo-tetradecahydro-1h-cyclopenta[a]chrysene-3a-carboxylic acid
(3s,4as,6as,6br,8ar,10r,12as,12br,13r,14br)-13-methoxy-2,2,4a,6a,6b,9,9,12a-octamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-3,10-diol
(4as,6as,6br,10s,11r,12ar)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(1r,3as,3br,4s,7s,9as,9bs,11ar)-1-[(2r,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-4-methoxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-ol
(1r,3as,5ar,5br,7ar,9s,10r,11ar,11br,13ar,13br)-9,10-dihydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
10-hydroxy-2-(hydroxymethyl)-2,4a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-6a-carboxylic acid
(2r,4as,6as,6br,8ar,9r,10r,12ar,12br,14br)-10-hydroxy-9-(hydroxymethyl)-2,4a,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid
(2s,4ar,5s,6as,6br,8ar,10s,12ar,12br,14bs)-5,10-dihydroxy-2-(hydroxymethyl)-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carbaldehyde
4,7-dihydroxy-1-(6-hydroxy-6-methylhept-4-en-2-yl)-3a,6,6,11a-tetramethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde
(1s,3s,5r,7r,10s,11r,14s,15r,18s,20r)-7-hydroxy-18-methoxy-1,6,6,10,15,19,19-heptamethylpentacyclo[12.8.0.0³,¹¹.0⁵,¹⁰.0¹⁵,²⁰]docosane-3-carbaldehyde
(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl docosanoate
1-(6-hydroperoxy-6-methylhept-4-en-2-yl)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one
(1r,2s,3ar,5ar,9as,11ar)-2-hydroxy-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-one
(1s,6r,8s,11r,12s,15s,16r,19s,20s,21r)-8,19-dihydroxy-20-(hydroxymethyl)-1,7,7,11,16,20-hexamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-5-one
(2r,4ar,6as,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-4a-(hydroxymethyl)-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid
2-[(1z,2s,3s,4s)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e)-4-methyl-6-[(1s,3s)-2,2,3-trimethyl-6-methylidenecyclohexyl]hex-3-en-1-yl]cyclohexylidene]propanal
n-[(1s,3as,3bs,5ar,6r,7s,9ar,9bs,11as)-6-(acetyloxy)-9a,11a-dimethyl-1-[(1s)-1-(methylamino)ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-3-methylbut-2-enimidic acid
(1s,4s,5r,8r,10s,13r,14r,16r,17s,18r)-10,16-dihydroxy-4,5,9,9,13,20,20-heptamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-23-one
(1s,2r,5s,7s,10r,11r,14r,15s,16s,18s,20s)-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosane-7,16-diol
(1r,4s,5r,8s,11r,13r,14s,17r,18s,21r,24r)-21-hydroxy-5,8,11,14,17,24-hexamethyl-22-oxahexacyclo[19.2.1.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosane-11-carboxylic acid
(2s,3r,5s)-5-[(1s)-1-[(1r,3ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3-isopropyloxolan-2-ol
(1s,2s,3as,5ar,9ar,9br,11as)-2-hydroxy-1-[(1r,2s,3r)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(1r,3as,3bs,4s,7s,9as,9br,11ar)-4,7-dihydroxy-1-[(2r,4r)-4-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,11a-tetramethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde
2-{7,9-dihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-methylhept-5-enoic acid
4-methoxy-2,3-dimethyl-6-[(2e,7r,11r)-3,7,11,15-tetramethylhexadec-2-en-1-yl]phenyl acetate
4,6-dihydroxy-7,12,16-trimethyl-15-(6-methylhept-5-en-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid
(1s,6r,7s,8s,11r,12s,15s,16r,19s,21r)-7-(hydroxymethyl)-19-methoxy-1,7,11,16,20,20-hexamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-ol
7,10-dihydroxy-1-(7-hydroxy-6-methylhept-5-en-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one
(1s,3as,5ar,9ar,9br,11as)-1-[(1r)-1-[(2s,3s)-3-[(1s)-1,2-dihydroxy-2-methylpropyl]oxiran-2-yl]ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
9,12-dihydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
[(1r,3as,3bs,4s,7s,9as,9bs,11ar)-4,7-dihydroxy-11a-methyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9a-yl]methyl acetate
2-[(1z,2r,3s,4s)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e)-4-methyl-6-[(1r,3s)-2,2,3-trimethyl-6-methylidenecyclohexyl]hex-3-en-1-yl]cyclohexylidene]propanal
1-(5,6-dimethylhept-3-en-2-yl)-5a,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate
(3ar,9as,9bs)-1-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybutan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(2r,4ar,6ar,6br,8as,10r,12ar,12bs,14br)-10-hydroxy-2-(hydroxymethyl)-2,4a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-6a-carboxylic acid
1,10-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(2s,4r,4ar,6br,10s,12ar,14bs)-4,10-dihydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid
(1s,3ar,3br,5ar,9as,9bs,10r,11as)-10-hydroxy-1-[(2s,5r)-5-isopropyl-2,5-dimethyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
9,23-dimethyl-30-oxa-11,25-diazapentacyclo[20.6.2.1⁷,¹¹.0²⁵,²⁹.0¹⁵,³¹]hentriacontan-8-one
C30H52N2O2 (472.40285719999997)
(1s,2s,4s,5r,8r,9r,10s,13s,14r,17s,18r)-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-2,10-diol
(1s,6r,8r,11r,12r,15s,16r,19r,20s,21r)-8,19-dihydroxy-20-(hydroxymethyl)-1,7,7,11,16,20-hexamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-5-one
(2s,4as,6ar,6bs,8as,9r,11r,12as,12bs,14as,14br)-11-hydroxy-2,4a,6a,8a,9,12b,14a-heptamethyl-10-oxo-tetradecahydro-1h-picene-2-carboxylic acid
(4ar,5s,6as,6br,10s,12ar,12br,14br)-5,10-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(1r,2s,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
4,10-dihydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid
3-[3-(5-isopropyl-2,5-dimethyloxolan-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid
10-hydroxy-9-(hydroxymethyl)-2,2,4a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-6a-carboxylic acid
(1s,2r,4as,6as,6br,8as,10s,12as,14ar,14br)-10,14a-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,5,6,7,8,8a,10,11,12,12b,14b-tetradecahydropicene-4a-carboxylic acid
2-(5-hydroxy-3-methylpent-3-en-1-yl)-6-[(6-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)methyl]-1-methyl-3-methylidenecyclohexane-1-carboxylic acid
(2r,4ar,6as,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-2-(hydroxymethyl)-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(3ar,3bs,5ar,9as,9bs,10s)-1-[(2r,4s,5s)-4,5-dihydroxy-6-methylhept-6-en-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(5as,6r,7r,9as)-6-{2-[(4ar,6r,8as)-6-hydroxy-2,5,5,8a-tetramethyl-3-oxo-4a,6,7,8-tetrahydro-4h-naphthalen-1-yl]ethyl}-2,2,5a,7-tetramethyl-hexahydro-4h-1-benzoxepin-3-one
(1r,3s,6s,8s,11r,12s,15r,16s,19r,21s)-8-methoxy-3,7,7,11,16,20,20-heptamethyl-24-oxahexacyclo[13.8.1.0¹,¹⁵.0³,¹².0⁶,¹¹.0¹⁶,²¹]tetracosan-19-ol
1-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybut-2-en-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
(3as,3bs,5ar,9as,9br,10s)-1-[(2s,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
2-[4-hydroxy-3-(hydroxymethyl)-2-(3-hydroxypropyl)-4-methyl-3-(4,8,12-trimethyltrideca-3,5,7,11-tetraen-1-yl)cyclohexylidene]propanal
2-[(1r,2s,5r)-2-[(2s,6s,8as)-6-hydroxy-8a-methyl-1-oxo-2,3,5,6,7,8-hexahydronaphthalen-2-yl]-5-[(2r,5r)-5,6-dimethylhept-3-en-2-yl]-1-methylcyclopentyl]ethyl acetate
(1r,2r,3r,6r,9r,10r,13s,14r)-13-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-2,5,5,9,10-pentamethyl-4-oxotetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadecane-3-carbaldehyde
(4ar,6ar,6br,8r,10s,12ar,12br,14br)-8,10-dihydroxy-2,2,4a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-6a-carboxylic acid
(1s,4as,6br,10r,12ar)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
(1s,3r,6s,8r,11s,12s,14s,15r,16r)-15-[(2s,4s)-4-hydroxy-6-methyl-5-methylideneheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-6,14-diol
(1r,3as,3bs,4s,7s,9as,9bs,11ar)-1-[(2r,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-4-methoxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-ol
(1r,3ar,5ar,7r,9as,11ar)-1-[(1s)-1-[(2s,5r,6r)-6-methoxy-5-methyloxan-2-yl]ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-ol
1-[1-(3,4-dihydroxy-5,5-dimethyloxolan-2-yl)ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,14b-dodecahydropicene-3,5,10-triol
(2r,3s,5z,8z,11z,14z,17z,20z,28s,29r)-2,29-diaminotriaconta-5,8,11,14,17,20-hexaene-3,28-diol
C30H52N2O2 (472.40285719999997)
(2z,5r,7e,11e)-2-[(4z)-6-hydroxy-4-(hydroxymethyl)hex-4-en-1-ylidene]-8,12,16-trimethyl-5-(prop-1-en-2-yl)heptadeca-7,11,15-trienoic acid
(1s,3ar,3br,5ar,9as,9br,10r,11ar)-10-hydroxy-1-[(2r)-2-hydroxy-6-methyl-4-oxohept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
4,7-dihydroxy-1-(4-hydroxy-6-methylhept-5-en-2-yl)-3a,6,6,11a-tetramethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde
(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-9-hydroxy-1-(3-hydroxyprop-1-en-2-yl)-5a,5b,8,8,11a-pentamethyl-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
(1s,3as,5ar,7s,9as,11as)-1-[(2s,5s)-5-hydroperoxy-6-methylhept-6-en-2-yl]-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one
(1s,3as,5ar,7s,9as,11as)-1-[(2s,4e)-6-hydroperoxy-6-methylhept-4-en-2-yl]-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one
3-[(3s,3ar,5ar,6s,7s,9ar,9br)-3-[(2s,5r)-5-isopropyl-2,5-dimethyloxolan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid
(1s,2r,4s,5r,8r,9r,10s,13s,14r,17s,18r)-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-2,10-diol
1-[5-(1-hydroxy-2-methylpropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
2,29-diaminotriaconta-5,8,11,14,17,20-hexaene-3,28-diol
C30H52N2O2 (472.40285719999997)
(1r,3as,3br,4s,7s,9as,9bs,11ar)-1-[(2r,4r)-4-hydroxy-6-methylhept-5-en-2-yl]-4-methoxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-ol
1-[(1s,2s,3as,3br,5ar,6r,7r,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2,6-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-3-(propan-2-ylidene)azetidin-2-one
13α,14α-epoxy-3β-methoxyserratan-21β-ol
{"Ingredient_id": "HBIN001128","Ingredient_name": "13\u03b1,14\u03b1-epoxy-3\u03b2-methoxyserratan-21\u03b2-ol","Alias": "NA","Ingredient_formula": "C31H52O3","Ingredient_Smile": "CC1(C2CCC34CC5(CCC6C(C(CCC6(C5CCC3(C2(CCC1O)C)O4)C)OC)(C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7165","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
13β,l4β-epoxy-3β-methoxyserratan-21β-ol
{"Ingredient_id": "HBIN001140","Ingredient_name": "13\u03b2,l4\u03b2-epoxy-3\u03b2-methoxyserratan-21\u03b2-ol","Alias": "NA","Ingredient_formula": "C31H52O3","Ingredient_Smile": "CC1(C2CCC34CC5(CCC6C(C(CCC6(C5CCC3(C2(CCC1O)C)O4)C)OC)(C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7166","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
14β,15β-epoxy-3β-methoxyserratan-21β-ol
{"Ingredient_id": "HBIN001378","Ingredient_name": "14\u03b2,15\u03b2-epoxy-3\u03b2-methoxyserratan-21\u03b2-ol","Alias": "NA","Ingredient_formula": "C31H52O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7167","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
22alpha-methoxyfaradiol
{"Ingredient_id": "HBIN003680","Ingredient_name": "22alpha-methoxyfaradiol","Alias": "NA","Ingredient_formula": "C31H52O3","Ingredient_Smile": "CC1C2C3CCC4C5(CCC(C(C5CCC4(C3(CC(C2(C(C=C1C)OC)C)O)C)C)(C)C)O)C","Ingredient_weight": "472.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9979;16250","PubChem_id": "10390082","DrugBank_id": "NA"}
3-methoxycycloart-23-ene-25,26-diol
{"Ingredient_id": "HBIN008823","Ingredient_name": "3-methoxycycloart-23-ene-25,26-diol","Alias": "NA","Ingredient_formula": "C31H52O3","Ingredient_Smile": "NA","Ingredient_weight": "472.74","OB_score": "NA","CAS_id": "142950-85-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8058","PubChem_id": "NA","DrugBank_id": "NA"}
4'-hydroxy-cis-cinnamicacid docosyl ester
{"Ingredient_id": "HBIN010529","Ingredient_name": "4'-hydroxy-cis-cinnamicacid docosyl ester","Alias": "NA","Ingredient_formula": "C31H52O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15820","TCMID_id": "9908","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
methyl 2-{5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl}-2-hydroxypropanoate
(1s,3s,5r,7r,10s,11r,14s,15r,18r,20r)-7-hydroxy-18-methoxy-1,6,6,10,15,19,19-heptamethylpentacyclo[12.8.0.0³,¹¹.0⁵,¹⁰.0¹⁵,²⁰]docosane-3-carbaldehyde
(1r,3ar,5ar,7r,9as,11ar)-1-[(1s)-1-[(2s,5r,6s)-6-methoxy-5-methyloxan-2-yl]ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-ol
1-[1-(6-methoxy-5-methyloxan-2-yl)ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-ol
n-[6-(acetyloxy)-9a,11a-dimethyl-1-[1-(methylamino)ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-2-methylbut-2-enimidic acid
n-[6-(acetyloxy)-9a,11a-dimethyl-1-[1-(methylamino)ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-3-methylbut-2-enimidic acid
(1r,3as,3br,4r,7s,9as,9bs,11ar)-1-[(2r,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-4-methoxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-ol
methyl (2s)-3-[(1r,2s,4as,4br,6ar,10as,10bs,12as)-2-ethyl-2,4b,6a,9,9,10b,12a-heptamethyl-dodecahydrochrysen-1-yl]-2-methylpropanoate
2-[(1z,2s,3r,4s)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e)-4-methyl-6-[(1r,5r)-2,5,6,6-tetramethylcyclohex-2-en-1-yl]hex-3-en-1-yl]cyclohexylidene]propanal
4-methoxy-2,3-dimethyl-6-[(7r,11r)-3,7,11,15-tetramethylhexadec-2-en-1-yl]phenyl acetate
1-(6-methoxy-2,5,5-trimethyloxan-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
methyl 6-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylheptanoate
13-methoxy-2,2,4a,6a,6b,9,9,12a-octamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-3,10-diol
(5e,8e,11e,14e,17e,20e)-2,29-diaminotriaconta-5,8,11,14,17,20-hexaene-3,28-diol
C30H52N2O2 (472.40285719999997)
(1r,2s,3s,4as,6as,6br,8ar,10r,12as,12br,13r,14br)-13-methoxy-1,2,4a,6a,6b,9,9,12a-octamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-3,10-diol
methyl (2s)-2-[(3s,3as,5ar,5br,7as,11as,11br,13ar,13bs)-5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl]-2-hydroxypropanoate
3-[3-(2-hydroxy-6-methyl-5-methylideneheptan-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid
22-methoxy-4,5,9,9,13,19,20-heptamethyl-21-oxahexacyclo[18.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-ol
15-(4-hydroxy-6-methyl-5-methylideneheptan-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-6,14-diol
1-(4-hydroxy-6-methylhept-5-en-2-yl)-4-methoxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-ol
(1s,3s,6r,8s,11r,12s,15s,16s,19r,21s)-8-methoxy-3,7,7,11,16,20,20-heptamethyl-24-oxahexacyclo[13.8.1.0¹,¹⁵.0³,¹².0⁶,¹¹.0¹⁶,²¹]tetracosan-19-ol
2-[4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[4-methyl-6-(2,5,6,6-tetramethylcyclohex-2-en-1-yl)hex-3-en-1-yl]cyclohexylidene]propanal
5-(1-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3-isopropyloxolan-2-ol
(2r,3s,5z,8z,11z,14z,17e,20z,28s,29r)-2,29-diaminotriaconta-5,8,11,14,17,20-hexaene-3,28-diol
C30H52N2O2 (472.40285719999997)
11-hydroxy-1-(2-hydroxy-6-methyl-5-methylideneheptan-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
(1r,3ar,3bs,5ar,9as,9br,10r,11as)-10-hydroxy-1-[(2s,5r)-5-isopropyl-2,5-dimethyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
(1s,4r,5r,8r,10s,13r,14r,17r,18s,19s,20r,22s)-22-methoxy-4,5,9,9,13,19,20-heptamethyl-21-oxahexacyclo[18.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-ol
8a-(hydroxymethyl)-14-methoxy-4,4,6a,6b,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-ol
8-methoxy-3,7,7,11,16,20,20-heptamethyl-24-oxahexacyclo[13.8.1.0¹,¹⁵.0³,¹².0⁶,¹¹.0¹⁶,²¹]tetracosan-19-ol
(1r,3as,3br,4s,7s,9as,9bs,11ar)-1-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-4,7-diol
(3r)-1-[(1s,2r,3as,3br,5ar,7s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-tetradecahydrocyclopenta[a]phenanthren-7-yl]-3-isopropylazetidin-2-one
n-{15-[1-(dimethylamino)ethyl]-3-hydroxy-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadec-1(18)-en-6-yl}-2-methylpropanimidic acid
C30H52N2O2 (472.40285719999997)
methyl 3-[(3s,3ar,5as,6s,7s,9ar,9br)-3-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate
(1s,3ar,3br,5ar,9ar,9br,11ar)-1-[(2s,6s)-6-methoxy-2,5,5-trimethyloxan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
(3s,4ar,6ar,6bs,8s,8ar,12as,14ar,14br)-8,8a-bis(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-ol
methyl 3-[3-(2-hydroxy-6-methylhept-5-en-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate
13-methoxy-1,2,4a,6a,6b,9,9,12a-octamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-3,10-diol
n-{1-[1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl}-3,4-dimethylpent-3-enimidic acid
C30H52N2O2 (472.40285719999997)
(1r,3as,3bs,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 2-ethoxyacetate
2-[4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[4-methyl-6-(2,2,3-trimethyl-6-methylidenecyclohexyl)hex-3-en-1-yl]cyclohexylidene]propanal
(3s,6r)-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-methoxy-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-2,3-dimethylheptan-2-ol
3-[(3s,3ar,5ar,6s,7s,9ar,9br)-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid
(2s,3r,5s)-5-[(1s)-1-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3-isopropyloxolan-2-ol
1-(6-methoxy-6-methylhept-4-en-2-yl)-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-4,7-diol
(1s,3ar,3br,5ar,9as,9br,10r,11ar)-10-hydroxy-1-[(2s,5r)-5-isopropyl-2,5-dimethyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
methyl 3-(2-ethyl-2,4b,6a,9,9,10b,12a-heptamethyl-dodecahydrochrysen-1-yl)-2-methylpropanoate
1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a,9b-hexamethyl-decahydro-1h-cyclopenta[a]phenanthren-7-one
(1r,4r,5r,8r,10s,13s,14r,17r,18r,19s,20s,22s)-22-methoxy-4,5,9,9,13,19,20-heptamethyl-21-oxahexacyclo[18.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-ol
(3s,4ar,6ar,6bs,8as,11r,12s,12as,14r,14ar,14bs)-8a-(hydroxymethyl)-14-methoxy-4,4,6a,6b,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-ol
(3s,4ar,6ar,6bs,8s,8as,11r,12s,12as,14r,14ar,14bs)-14-methoxy-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picene-3,8-diol
(1r,3ar,5ar,7r,9as,11ar)-1-[(1s)-1-[(2s,5r)-6-methoxy-5-methyloxan-2-yl]ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-ol
(1s,3ar,3br,5ar,9ar,9br,11ar)-1-[(2s,5s)-5-(1-hydroxy-2-methylpropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
methyl (2r,6r)-6-[(1s,3as,5ar,7s,9ar,9bs,11as)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylheptanoate
3-[(3s,3ar,5as,6s,7s,9ar,9br)-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid
2-[(1e,2r,3s,4s)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e)-4-methyl-6-[(1r,3s)-2,2,3-trimethyl-6-methylidenecyclohexyl]hex-3-en-1-yl]cyclohexylidene]propanal
methyl (2r,6r)-6-[(1s,3as,5ar,7r,9ar,9bs,11as)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylheptanoate
(1r,3as,3br,4r,7s,9as,9bs,11ar)-1-[(2r,4r)-4-hydroxy-6-methylhept-5-en-2-yl]-4-methoxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-ol
n-[(1s,3as,3bs,5ar,6r,7s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-3,4-dimethylpent-3-enimidic acid
C30H52N2O2 (472.40285719999997)
2-[(1z,2r,3s,4s)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e)-4-methyl-6-[(1r,5s)-2,5,6,6-tetramethylcyclohex-2-en-1-yl]hex-3-en-1-yl]cyclohexylidene]propanal
(1s,3ar,3br,5ar,9ar,9br,11r,11ar)-11-hydroxy-1-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
(3s)-1-[(1s,2s,3as,3br,5ar,7s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-tetradecahydrocyclopenta[a]phenanthren-7-yl]-3-isopropylazetidin-2-one
2-[(1z,2s,3r,4r)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e)-4-methyl-6-[(1s,5r)-2,5,6,6-tetramethylcyclohex-2-en-1-yl]hex-3-en-1-yl]cyclohexylidene]propanal
(1s,3ar,3br,5as,9ar,9br,11r,11ar)-11-hydroxy-1-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
7-hydroxy-18-methoxy-1,6,6,10,15,19,19-heptamethylpentacyclo[12.8.0.0³,¹¹.0⁵,¹⁰.0¹⁵,²⁰]docosane-3-carbaldehyde
7-ethyl-20-(hydroxymethyl)-1,7,11,16,20-pentamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-ene-8,19-diol
(2r,3s,5s)-5-[(1s)-1-[(1r,3ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3-isopropyloxolan-2-ol
(1r,3s,6ar,6bs,8ar,11r,12s,12ar,14r,14bs)-14-methoxy-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picene-1,3-diol
(1s,6r,7r,8s,11r,12s,15s,16r,19s,20s,21r)-7-ethyl-20-(hydroxymethyl)-1,7,11,16,20-pentamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-ene-8,19-diol
(1r,2r,3s,4r,6as,6br,12ar,14s)-1,2,3,4,6a,6b,9,9,12a-nonamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14-tetradecahydro-2h-picene-1,10,14-triol
n-[(3s,6s,8s,11r,12s,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-3-hydroxy-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadec-1(18)-en-6-yl]-2-methylpropanimidic acid
C30H52N2O2 (472.40285719999997)